A Randomized Double Blind, Placebo Controlled Clinical Study Evaluating the Efficacy and Safety of Magnesium Supplementation on Relaxation in Adults

Inclusion criteria

• Healthy participants (women + men)
• Will maintain regular diet and exercise habits
• Agreement to adhere to the procedures and requirements of the study and to report to the institute on the day(s) and at the time(s) scheduled for the assessments.

Exclusion criteria

• Neurological or psychiatric disorders
• Pregnant or breastfeeding
• Known allergies to magnesium-containing products
• Taking a medication known to interact with magnesium, or taking loop diuretics, cyclosporine, digoxin, amphotericin.
• No concurrent magnesium supplementation
• Substance or alcohol abuse
• Currently use, or have used within appropriate washout period, any prescription, over the counter medication, or supplements with primary CNS activity such as Antidepressants,mood stabilizer and anxiolytics, Sedatives and Stimulants
• Anticholinergic or cholinergic medications
• Anti-inflammatory and analgesic medication (except for PRN use)
• Anti-allergy medication (except for non-sedating antihistamines)
• Blood thinners
• Other prescribed medications that may affect cognition, stress, or mood
• Body mass index (BMI) greater than 40 kg/m2 ,
• Individuals on angiotensin converting enzyme inhibitors for blood pressure control, other magnesium-retaining drugs, or potassium-sparing drugs
• History of reaction to the category of product tested
• Other diseases or medications that might directly interfere in the study or put the subject's health under risk.
• Subjects with any invasive medical procedures during the study.
• Participants who are unreliable or unlikely to be available for the duration of the study.
• No employees of PCR or the sponsor (e.g OLLY PBC, Unilever, or the H&W Collective)